Skip to content
Syntropya
Log inRequest a demo

IFRS 17 · Life & non-life · Reporting

Every reserve, reconciled.

Syntropya turns your actuarial methodology into governed, reproducible production, from raw data to regulatory disclosures.

Request a demoLog in

A Novacture platform.

Quarterly closing

Illustrative data

2026-Q2 closing

valuation date
30/06/2026
scope
full closing

Closing stages: three completed, valuation in progress, disclosures pending

  • Data gathering & qualityControlled
  • Business rules & assumptionsApproved
  • Projections · LRC · LIC · actualsDone
  • IFRS 17 valuationIn progress
  • DisclosuresPending
Results · insurance contract liabilities
CU 0002026-Q12026-Q2
Present value of future cash flows179,410184,320
Risk adjustment12,10512,540
Contractual service margin41,28038,960
Liability for incurred claims26,98027,615
Insurance contract liabilities259,775263,435
Baseline: approved 2026-Q1 closingAudit trail
Illustrative quarterly closing on fictional figures: data, assumptions and projections completed, IFRS 17 valuation in progress, disclosures pending, and the resulting insurance contract liabilities in thousands of currency units.

Capabilities

The whole closing, on one governed platform.

From the first data extract to the published disclosures, each stage is controlled and documented.

  • 01

    Data gathering & quality

    Policy, claims and accounting data collected and controlled at entry. Quality issues are reported before any calculation starts.

  • 02

    Business rules & assumptions

    Management rules and actuarial assumptions documented, versioned and approved, then applied the same way at every closing.

  • 03

    Product modelling

    Life and non-life products: cash-flow projections, LRC, LIC, actuals versus expected and the risk adjustment.

  • 04

    IFRS 17 & regulatory reporting

    Valuation, accounting mapping and disclosures produced by the platform and exportable for review.

  • 05

    Scenarios & sensitivities

    Adjust an assumption or a data set for one calculation and compare it with the approved baseline. The baseline itself never changes.

  • 06

    Audit & governance

    Every figure traceable to its data, assumptions and model version. Each run keeps its own inputs and results, and every administrative change is logged.

Solutions

Standard where it can be, tailored where it must be.

Two ways to start, one platform underneath: the same controls, audit trail and reporting either way.

  • Standardised modules

    Ready to deploy, configured to your data.

    Proven modules for the core of the closing. Fast to start: we connect your data and calibrate the parameters, the methodology is already in place.

    • IFRS 17 valuation & reporting
    • Life projections
    • Non-life projections

  • Customised solutions

    Your products, your rules, your methodology.

    Built with Novacture’s actuaries around your portfolio and your business rules, then run on the same governed platform as the standard modules.

    • Specific products and guarantees
    • Your management rules and assumptions
    • Local regulatory and management reporting

Method

From methodology to production.

Every solution is built the same way, with your actuaries, and is only put into production once it reconciles with the results you already trust.

  1. 01

    Data gathering

    Map the sources, agree data contracts with your teams and control quality at entry.

  2. 02

    Modelling

    Formalise business rules, assumptions and calculation logic with your actuaries.

  3. 03

    Industrialisation

    Implement the model in tested, versioned Python on the platform.

  4. 04

    Testing & validation

    Reconcile with your existing results; regression tests against approved reference results.

  5. 05

    Audit & production

    Documentation, audit trail and sign-off. From then on, every closing runs on it.

Scenarios & sensitivities

Ask “what if” without touching the closing.

Adjust an assumption or a data set for one calculation and compare it with the approved baseline. The baseline itself never changes.

Management sees the impact of a rate shock, a lapse assumption or a corrected data set on the same basis as the published figures, before deciding. Each run keeps its own inputs and results, next to the approved baseline it is compared with.

Discount curve −50 bp

Illustrative data
CU 000BaselineScenarioImpact
Present value of future cash flows184,320191,8707,550
Risk adjustment12,54012,995455
Contractual service margin38,96030,955(8,005)
Approved 2026-Q2 baseline unchanged

Governance

Every number has to hold.

For your board, your auditors and your regulator. Controls are part of the closing, not added after it.

  • Board & executive management
  • Chief actuary
  • Finance & reporting
  • Auditors
  • Regulators
  • IT & data

Traceability

From disclosure back to source
Every figure leads back to the data, the assumptions and the model version that produced it.

Reproducibility

Every run keeps its record
Each run keeps its own inputs and results, so a past closing can be reopened and explained to an auditor or a regulator.

Approval

Segregation of duties
Administrators publish the reference data of each closing; analysts run their calculations on it. Runs are compared with the approved baseline.

Access

Access per solution and per closing
Each user is granted the solutions and closings they work on. Every administrative change is logged and searchable.

See a closing, end to end.

A 45-minute walkthrough on illustrative data, with the actuaries and engineers who build Syntropya.

Request a demoLog in
Syntropya — Every reserve, reconciled.